Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387207054> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4387207054 endingPage "e533" @default.
- W4387207054 startingPage "e533" @default.
- W4387207054 abstract "Chemoradiation (CRT) remains the standard of care for locally advanced cervical cancer. As recent large phase III trials (OUTBACK, CALLA) reported no difference in primary survival outcomes when novel agents were added to CRT, technological advancements continue to be a focus for improving outcomes. Daily imaging has enabled margin reduction on the cervix, uterus and lymph nodes, which can lower radiation dose to bowel and potentially reduce RT-related symptoms. Daily adaptive RT (ART) combines daily imaging with online dosimetry replanning, allowing for decreased margins on the target. A pre-planning study showed bowel V40Gy and V45Gy reductions of 252 cc to140 cc and 167 cc to 43 cc, respectively. ARTIA-Cervix is a single-arm, prospective, multi-institutional, international clinical trial investigating the potential of ART to decrease patient-reported acute gastrointestinal (GI) toxicity.Planned enrollment is 125 subjects with up to 8 sites participating. Eligibility criteria include locally advanced node-negative cervical cancer FIGO stages IB2-3B. Treatment will consist of cisplatin-based CRT with daily ART, followed by image-guided brachytherapy. Subjects will receive 25 fractions ART at 1.8 Gy per day for a total of 45 Gy. The primary study objective is reduction of patient-reported GI toxicity as measured by PRO-CTCAE score ≥3 at the conclusion of ART. Secondary objectives include patient-reported GU toxicity and sexual quality of life, the development of radiation dosimetry models predicting toxicity, physician-reported toxicities, 2-year disease free survival, and adaptive workflow metrics. Powering of the study and sample size calculation are based on the hypothesis that ART will decrease patient-reported acute GI toxicity from historical rates of 33% to 20% (13% effect size).This study opened to enrollment on April 28th, 2022. The total study duration will be approximately 5 years.ARTIA-Cervix is an international, prospective clinical trial designed to evaluate reduction of treatment-related GI toxicity through daily online ART. The results of this clinical study will add to the growing body of evidence supporting clinical decisions about utilization of ART technologies." @default.
- W4387207054 created "2023-09-30" @default.
- W4387207054 creator A5003381572 @default.
- W4387207054 creator A5012307259 @default.
- W4387207054 creator A5022455419 @default.
- W4387207054 creator A5022738856 @default.
- W4387207054 creator A5026426772 @default.
- W4387207054 creator A5039555075 @default.
- W4387207054 creator A5050839613 @default.
- W4387207054 creator A5053860074 @default.
- W4387207054 creator A5055980660 @default.
- W4387207054 creator A5069787460 @default.
- W4387207054 creator A5083998914 @default.
- W4387207054 date "2023-10-01" @default.
- W4387207054 modified "2023-10-17" @default.
- W4387207054 title "ARTIA-Cervix: A Prospective Clinical Trial to Assess Patient Reported Intestinal Toxicity with Adaptive External Beam Radiation Therapy in the Treatment of Cervical Cancer" @default.
- W4387207054 doi "https://doi.org/10.1016/j.ijrobp.2023.06.1817" @default.
- W4387207054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37785652" @default.
- W4387207054 hasPublicationYear "2023" @default.
- W4387207054 type Work @default.
- W4387207054 citedByCount "0" @default.
- W4387207054 crossrefType "journal-article" @default.
- W4387207054 hasAuthorship W4387207054A5003381572 @default.
- W4387207054 hasAuthorship W4387207054A5012307259 @default.
- W4387207054 hasAuthorship W4387207054A5022455419 @default.
- W4387207054 hasAuthorship W4387207054A5022738856 @default.
- W4387207054 hasAuthorship W4387207054A5026426772 @default.
- W4387207054 hasAuthorship W4387207054A5039555075 @default.
- W4387207054 hasAuthorship W4387207054A5050839613 @default.
- W4387207054 hasAuthorship W4387207054A5053860074 @default.
- W4387207054 hasAuthorship W4387207054A5055980660 @default.
- W4387207054 hasAuthorship W4387207054A5069787460 @default.
- W4387207054 hasAuthorship W4387207054A5083998914 @default.
- W4387207054 hasConcept C121608353 @default.
- W4387207054 hasConcept C126322002 @default.
- W4387207054 hasConcept C143998085 @default.
- W4387207054 hasConcept C188816634 @default.
- W4387207054 hasConcept C2775908122 @default.
- W4387207054 hasConcept C2777416452 @default.
- W4387207054 hasConcept C2777740455 @default.
- W4387207054 hasConcept C2778220009 @default.
- W4387207054 hasConcept C29730261 @default.
- W4387207054 hasConcept C509974204 @default.
- W4387207054 hasConcept C535046627 @default.
- W4387207054 hasConcept C71924100 @default.
- W4387207054 hasConceptScore W4387207054C121608353 @default.
- W4387207054 hasConceptScore W4387207054C126322002 @default.
- W4387207054 hasConceptScore W4387207054C143998085 @default.
- W4387207054 hasConceptScore W4387207054C188816634 @default.
- W4387207054 hasConceptScore W4387207054C2775908122 @default.
- W4387207054 hasConceptScore W4387207054C2777416452 @default.
- W4387207054 hasConceptScore W4387207054C2777740455 @default.
- W4387207054 hasConceptScore W4387207054C2778220009 @default.
- W4387207054 hasConceptScore W4387207054C29730261 @default.
- W4387207054 hasConceptScore W4387207054C509974204 @default.
- W4387207054 hasConceptScore W4387207054C535046627 @default.
- W4387207054 hasConceptScore W4387207054C71924100 @default.
- W4387207054 hasIssue "2" @default.
- W4387207054 hasLocation W43872070541 @default.
- W4387207054 hasLocation W43872070542 @default.
- W4387207054 hasOpenAccess W4387207054 @default.
- W4387207054 hasPrimaryLocation W43872070541 @default.
- W4387207054 hasRelatedWork W1970876854 @default.
- W4387207054 hasRelatedWork W2384708512 @default.
- W4387207054 hasRelatedWork W2404243584 @default.
- W4387207054 hasRelatedWork W2916147875 @default.
- W4387207054 hasRelatedWork W2966036943 @default.
- W4387207054 hasRelatedWork W3029213237 @default.
- W4387207054 hasRelatedWork W3029595631 @default.
- W4387207054 hasRelatedWork W3104537559 @default.
- W4387207054 hasRelatedWork W4206581437 @default.
- W4387207054 hasRelatedWork W4237106564 @default.
- W4387207054 hasVolume "117" @default.
- W4387207054 isParatext "false" @default.
- W4387207054 isRetracted "false" @default.
- W4387207054 workType "article" @default.